Item 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
| Total Number of Shares Purchased (1) | Average Price Paid per Share (2) | Total Number of Shares Purchased as Part of the Publicly Announced Common Stock Repurchase Plan (1) | Maximum Approximate Dollar Value of Shares that may yet be Purchased under the Common Stock Repurchase Plan (1) (2) | |||||||||||||||||||||||
| Period | ||||||||||||||||||||||||||
| October 1 to 31, 2025 | 519,252 | $ | 284.20 | 519,252 | $ | 1,286,258,009 | ||||||||||||||||||||
| November 1 to 30, 2025 | 674,012 | $ | 256.23 | 674,012 | $ | 1,113,558,970 | ||||||||||||||||||||
| December 1 to 31, 2025 | 741,860 | $ | 262.74 | 741,860 | $ | 918,641,111 | ||||||||||||||||||||
| Total | 1,935,124 | 1,935,124 |
| (1) | The Company received the Board of Directors' approval in November 2022 to repurchase $5 billion of its common stock, as reflected in the table above. In January 2026, the Company received the Board of Directors' approval to repurchase $6 billion of its common stock, which replaces in its entirety the previous 2022 authorization. | |||||||
| (2) | Inclusive of the impact of the one-percent excise tax under the Inflation Reduction Act of 2022. |
There is no expiration date for the common stock repurchase authorization.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details